For example, it was reported that although insulin secretion potentiation with GIP infusion reaches a plateau at ca. 100 pmol/L GIP similarly in glucose tolerant individuals and T2D, GIP stimulated insulin release is reduced by ca. 50% in diabetic patients [25]. Here, GIP is linked to type 2 diabetes mellitus.